Eur Respir J 2002; 20:841-845
Copyright ©ERS Journals Ltd 2002
Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
L. Lehtimäki1,2,
H. Kankaanranta1,3,
S. Saarelainen3,
V. Turjanmaa4 and
E. Moilanen1,2
1 The Immunopharmacological Research Group, Medical School, University of Tampere, Depts of 2 Clinical Chemistry, 3 Respiratory Medicine and 4 Clinical Physiology, Tampere University Hospital, Tampere, Finland
CORRESPONDENCE: E. Moilanen, Medical School, FIN-33014 University of Tampere, Tampere, Finland. Fax: 358 32158082. E-mail: eeva.moilanen@uta.fi
Keywords: asthma, bronchi, exhaled nitric oxide, inflammation, nocturnal, pulmonary alveoli
Received: January 15, 2002
Accepted May 9, 2002
The study was supported by grants from the National Technology Agency (Tekes), the Medical Research Fund of Tampere University Hospital, Tampere Tuberculosis Foundation, Jalmari and Rauha Ahokas Foundation, and the Academy of Finland.
Nocturnal asthma symptoms and impaired lung function at night are related to inflammatory activity in the peripheral lung compartment. Exhaled nitric oxide (NO) measurement at multiple exhalation flow rates can be used to separately assess alveolar and bronchial NO production and inflammation. The authors hypothesised that asthmatic patients with nocturnal symptoms have a higher alveolar NO concentration than those with only daytime symptoms.
The authors asked 40 patients with newly-diagnosed steroid-naïve asthma about their nocturnal asthma symptoms through the use of a written questionnaire. Alveolar NO concentration and bronchial NO flux were assessed in the 40 asthmatics and 40 healthy controls.
Nineteen of the 40 patients reported nocturnal symptoms. Patients with nocturnal symptoms had a higher alveolar NO concentration (1.7±0.3 (mean±sem) parts per billion (ppb)) than patients without nocturnal symptoms (0.8±0.3 ppb, p=0.012) or healthy controls (1.0±0.1 ppb, p=0.032). Bronchial NO flux was higher both in patients with (2.4±0.4 nL·s1, p<0.001) and without (2.6±0.4 nL·s1, p<0.001) nocturnal symptoms, compared to controls (0.7±0.1 nL·s1).
Nocturnal symptoms in asthmatic patients are related to a higher alveolar nitric oxide concentration. The results suggest that assessment of alveolar nitric oxide concentration can be used to detect the parenchymal inflammation in asthmatic patients with nocturnal symptoms.
This article has been cited by other articles:

|
 |

|
 |
 
G. Rodway, J Choi, L. Hoffman, and J. Sethi
Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications
Chronic Respiratory Disease,
February 1, 2009;
6(1):
19 - 29.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malinovschi, C. Janson, L. Holm, L. Nordvall, and K. Alving
Basal and induced NO formation in the pharyngo-oral tract influences estimates of alveolar NO levels
J Appl Physiol,
February 1, 2009;
106(2):
513 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Suresh, D. A. Shelley, H.-W. Shin, and S. C. George
Effect of heterogeneous ventilation and nitric oxide production on exhaled nitric oxide profiles
J Appl Physiol,
June 1, 2008;
104(6):
1743 - 1752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lehtonen, P. Oksa, L. Lehtimaki, A. Sepponen, R. Nieminen, H. Kankaanranta, S. Saarelainen, R. Jarvenpaa, J. Uitti, and E. Moilanen
Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis
Thorax,
July 1, 2007;
62(7):
602 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Paraskakis, C. Brindicci, L. Fleming, R. Krol, S. A. Kharitonov, N. M. Wilson, P. J. Barnes, and A. Bush
Measurement of Bronchial and Alveolar Nitric Oxide Production in Normal Children and Children with Asthma
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
260 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. van Veen, P. J. Sterk, R. Schot, S. A. Gauw, K. F. Rabe, and E. H. Bel
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Eur. Respir. J.,
May 1, 2006;
27(5):
951 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brindicci, K. Ito, O. Resta, N. B. Pride, P. J. Barnes, and S. A. Kharitonov
Exhaled nitric oxide from lung periphery is increased in COPD
Eur. Respir. J.,
July 1, 2005;
26(1):
52 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Ratnawati and P S Thomas
Exhaled nitric oxide in paediatric asthma
Chronic Respiratory Disease,
July 1, 2005;
2(3):
163 - 174.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Berry, B. Hargadon, A. Morgan, M. Shelley, J. Richter, D. Shaw, R. H. Green, C. Brightling, A. J. Wardlaw, and I. D. Pavord
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma
Eur. Respir. J.,
June 1, 2005;
25(6):
986 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005
Am. J. Respir. Crit. Care Med.,
April 15, 2005;
171(8):
912 - 930.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Gelb, C. F. Taylor, E. Nussbaum, C. Gutierrez, A. Schein, C. M. Shinar, M. J. Schein, J. D. Epstein, and N. Zamel
Alveolar and Airway Sites of Nitric Oxide Inflammation in Treated Asthma
Am. J. Respir. Crit. Care Med.,
October 1, 2004;
170(7):
737 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Mahut, C. Delacourt, F. Zerah-Lancner, J. De Blic, A. Harf, and C. Delclaux
Increase in Alveolar Nitric Oxide in the Presence of Symptoms in Childhood Asthma
Chest,
March 1, 2004;
125(3):
1012 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|
|